Eder, P. A.
1546  Ergebnisse:
Personensuche X
?
1

P621 Safety and effectiveness of vedolizumab and ustekinuma..:

Holvoet, T ; Verstockt, B ; Lenfant, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1195-i1196 , 2024
 
?
2

P508 Pre-operative exposure to tofacitinib is as safe as bi..:

Dragoni, G ; Innocenti, T ; Amiot, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1005-i1006 , 2024
 
?
4

P510 Relapse rate following withdrawal of vedolizumab and u..:

Albshesh, A ; Kucha, P ; Mahajna, H...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1009-i1010 , 2024
 
?
5

P1138 Long-term Epidemiological Trends in Emergency Hospita..:

Mahadea, D ; Kotecki, P ; Miechowicz, I..
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i2037-i2038 , 2024
 
?
6

P421 Real-world effectiveness and safety of vedolizumab ind..:

Liebert, A ; Kłopocka, M ; Cichoż-Lach, H...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i550-i551 , 2023
 
?
 
?
9

P647 Idiopathic Thrombocytopenic Purpura associated with In..:

Mahajna, H ; Verstockt, B ; Bergemalm, D...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i561-i561 , 2022
 
?
 
?
11

DOP79 Primary hypogammaglobulinemia with IBD-like features:..:

Albshesh, A ; Eder, P ; Ribaldone, D G...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S111-S111 , 2021
 
?
13

P824 Molecular predictors of anti-TNF treatment response in..:

WALCZAK, M ; Lykowska-Szuber, L ; Plucinska, M...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S640-S640 , 2020
 
?
 
?
 
1-15